CNMD FY 2008 Earnings Report — CONMED Corporation Revenue & Financial Results | Market Cap Arena

CONMED CorporationCNMD

FY 2008 Earnings

Reported February 24, 2009

Quarter Comparison

Revenue

Operating Income

Gross Margin

Net Margin

EPS (Diluted)

Free Cash Flow

Metric	FY 2008	Prior Q	FY 2007	QoQ Change	YoY Change
Revenue	$742M	—	$694M	—	6.9%
Op. Income	$75M	—	$81M	—	-7.1%
Gross Margin	51.5%	—	50.3%	—	1.2pp
Net Margin	6.0%	—	6.0%	—	0.0pp
EPS (Diluted)	$1.52	—	$1.43	—	6.3%
Free Cash Flow	$25M	—	$45M	—	-43.8%

Revenue Flow

Item	Amount
REVENUE	$742M
Cost of Revenue	$360M
GROSS PROFIT	$382M
R&D Expenses	$33M
Selling & Marketing	$0
General & Administrative	$272M
SG&A Expenses	$272M
Other Expenses	$2M
Operating Expenses	$307M
Cost & Expenses	$667M
OPERATING INCOME	$75M
Interest Income	$0
Interest Expense	$10M
Other Income/Expenses	-$6M
INCOME BEFORE TAX	$69M
Income Tax Expense	$25M
Net Income from Continuing Ops	$45M
Net Income from Discontinued Ops	$0
Other Adjustments	$0
NET INCOME	$45M
Net Income Deductions	$5M
BOTTOM LINE NET INCOME	$40M
D&A	$32M
EBIT	$72M
EBITDA	$112M
EPS	$2
EPS Diluted	$2

Income Statement

Item	Amount
REVENUE	$742M
Cost of Revenue	$360M
GROSS PROFIT	$382M
R&D Expenses	$33M
Selling & Marketing	$0
General & Administrative	$272M
SG&A Expenses	$272M
Other Expenses	$2M
Operating Expenses	$307M
Cost & Expenses	$667M
OPERATING INCOME	$75M
Interest Income	$0
Interest Expense	$10M
Other Income/Expenses	-$6M
INCOME BEFORE TAX	$69M
Income Tax Expense	$25M
Net Income from Continuing Ops	$45M
Net Income from Discontinued Ops	$0
Other Adjustments	$0
NET INCOME	$45M
Net Income Deductions	$5M
BOTTOM LINE NET INCOME	$40M
D&A	$32M
EBIT	$72M
EBITDA	$112M
EPS	$2
EPS Diluted	$2

Cash Flow Statement

Item	Amount
Net Income	$45M
Depreciation & Amortization	$32M
Stock-Based Compensation	$4M
Deferred Income Tax	$19M
Other Non-Cash Items	-$13M
Change in Working Capital	-$26M
OPERATING CASH FLOW	$61M
Capital Expenditure	-$36M
Acquisitions (Net)	-$22M
Purchases of Investments	$0
Sales/Maturities of Investments	$0
Other Investing Activities	$0
NET CASH FROM INVESTING	-$58M
Net Debt Issuance	-$14M
Common Stock Repurchased	$0
Common Dividends Paid	$0
Other Financing Activities	$2M
NET CASH FROM FINANCING	-$5M
FREE CASH FLOW	$25M
Net Change in Cash	$116.0K

Balance Sheet

Item	Amount
Cash & Equivalents	$12M
Short-Term Investments	$0
Net Receivables	$97M
Inventory	$160M
Other Current Assets	$14M
TOTAL CURRENT ASSETS	$294M
PP&E (Net)	$144M
Goodwill	$290M
Intangible Assets	$196M
Long-Term Investments	-$15M
Tax Assets	$15M
Other Non-Current Assets	$7M
TOTAL NON-CURRENT ASSETS	$637M
TOTAL ASSETS	$932M
Account Payables	$36M
Short-Term Debt	$3M
Deferred Revenue	$21M
Other Current Liabilities	$14M
TOTAL CURRENT LIABILITIES	$75M
Long-Term Debt	$196M
Deferred Revenue NC	$0
Deferred Tax Liabilities	$83M
Other Non-Current Liabilities	$45M
TOTAL NON-CURRENT LIABILITIES	$325M
TOTAL LIABILITIES	$400M
Common Stock	$313.0K
Additional Paid-In Capital	$292M
Retained Earnings	$327M
Treasury Stock	-$57M
Accum. Other Comp. Income	-$31M
Other Equity	$0
TOTAL STOCKHOLDERS' EQUITY	$532M
Minority Interest	$0
TOTAL EQUITY	$532M
TOTAL LIABILITIES & EQUITY	$932M
Total Debt	$199M
Net Debt	$188M